Gene · 4688
Papers3,069
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
341 to 360 of 3,069
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Molecular subtypes of ALS are associated with differences in patient prognosis. | Nat Commun | 2023 | 36609402 | PubTator, text mining | PubMed |
| Immune infiltration and immunophenotyping in atrial fibrillation. | Aging (Albany NY) | 2023 | 36602538 | PubTator, text mining | PubMed |
| Distinct gene signatures of monocytes and B cells in patients with giant cell arteritis: a longitudinal transcriptome analysis. | Arthritis Res Ther | 2023 | 36597161 | PubTator, text mining | PubMed |
| COVID-19 plasma proteome reveals novel temporal and cell-specific signatures for disease severity and high-precision disease management. | J Cell Mol Med | 2023 | 36537107 | PubTator, text mining | PubMed |
| Recent topics and advanced therapies in chronic granulomatous disease. | Hum Cell | 2023 | 36534309 | PubTator, text mining | PubMed |
| Impact of SARS-CoV-2 infection and COVID-19 on patients with inborn errors of immunity. | J Allergy Clin Immunol | 2023 | 36522221 | PubTator, text mining | PubMed |
| Knockdown of Stromal Interaction Molecule 1 (STIM1) Suppresses Acute Myeloblastic Leukemia-M5 Cell Line Survival Through Inhibition of Reactive Oxygen Species Activities | Turk J Haematol | 2023 | 36404683 | PubTator, text mining | PubMed |
| Microbes and the fate of neutrophils. | Immunol Rev | 2023 | 36345955 | PubTator, text mining | PubMed |
| Proteomics reveals antiviral host response and NETosis during acute COVID-19 in high-risk patients. | Biochim Biophys Acta Mol Basis Dis | 2023 | 36328146 | PubTator, text mining | PubMed |
| Novel insights into the mechanism of reactive oxygen species-mediated neurodegeneration. | Neural Regen Res | 2023 | 36204830 | PubTator, text mining | PubMed |
| Berbamine Hydrochloride inhibits lysosomal acidification by activating Nox2 to potentiate chemotherapy-induced apoptosis via the ROS-MAPK pathway in human lung carcinoma cells. | Cell Biol Toxicol | 2023 | 36070022 | PubTator, text mining | PubMed |
| Intratumoral pro-oxidants promote cancer immunotherapy by recruiting and reprogramming neutrophils to eliminate tumors. | Cancer Immunol Immunother | 2023 | 36066649 | PubTator, text mining | PubMed |
| De Novo Somatic Mosaicism of CYBB Caused by Intronic LINE-1 Element Insertion Resulting in Chronic Granulomatous Disease. | J Clin Immunol | 2023 | 35997928 | PubTator, text mining | PubMed |
| Elevated Fibroblast Growth Factor 23 Impairs Endothelial Function through the NF-κB Signaling Pathway. | J Atheroscler Thromb | 2023 | 35314565 | PubTator, text mining | PubMed |
| Transcriptome Analysis of Bovine Macrophages (BoMac) Cells after Infection with Bovine Immunodeficiency Virus. | J Vet Res | 2022 | 36846036 | PubTator, text mining | PubMed |
| ABI3BP is a prognosis biomarker related with clinicopathological features and immunity infiltration of lung tumor. | Front Genet | 2022 | 36744181 | PubTator, text mining | PubMed |
| Chronic granulomatous disease associated with Duchenne muscular dystrophy caused by Xp21.1 contiguous gene deletion syndrome: Case report and literature review. | Front Genet | 2022 | 36712874 | PubTator, text mining | PubMed |
| Epigenetic modifications in chronic rhinosinusitis with and without nasal polyps. | Front Genet | 2022 | 36699454 | PubTator, text mining | PubMed |
| Chemical synthesis of a reported p47phox/p22phox inhibitor and characterization of its instability and irreproducible activity. | Front Pharmacol | 2022 | 36686674 | PubTator, text mining | PubMed |
| Genipin Attenuates Diabetic Cognitive Impairment by Reducing Lipid Accumulation and Promoting Mitochondrial Fusion via FABP4/Mfn1 Signaling in Microglia. | Antioxidants (Basel) | 2022 | 36670935 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/4688/papers?page=18